-0.31 (-7.6%)



Type Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID IQL-13012021-00001
Subject OTHERS
Binding Term Sheet Agreement ("Agreement") between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad and Sinovac Life Sciences Co. Ltd.
Query Letter Contents

We refer to Pharma’s announcement dated 12 January 2021 in respect of the aforesaid matter.

In this connection, kindly furnish Bursa Securities with the following additional information for public release:


1) Whether PLS possesses the required expertise, knowhow and resources to manufacture the Covid-19 vaccine.

2) The tentative timeframe to enter into the Local Manufacturing Agreement and a Technology and Know-How License       Agreement with SINOVAC LS.

3) The risks in relation to the manufacturing of the Covid-19 vaccine that PLS may be exposed to.

4) To elaborate the manner in which PLS intends to market and distribute the Covid-19 vaccine and whether any               contract has been secured todate.

5) To specify the relevant authorities’ approvals required for the clinical trial of the Covid-19 vaccine and the                       manufacturing, distribution and sale of the Covid-19 vaccine in Malaysia together with the status of approval,                 where applicable.

6) The estimated total capital outlay or costs to be incurred and the source of funding for the  manufacturing of Covid-      19 vaccine.


Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.


Yours faithfully





cc: Market Surveillance Dept.  Securities Commission (via fax)

Reference is made to Company's announcement on 12 January 2021 and Bursa Malaysia Securities Berhad ("Bursa Securities")'s query letter dated 13 January 2021  pertaining to the above matter.


Please refer to the attachment for the full text of the Company's reply to Bursa Securities.


This announcement is dated 14 January 2021.


Please refer attachment below.

Please refer attachment below.

Announcement Info

Stock Name PHARMA
Date Announced 14 Jan 2021
Category General Announcement for PLC
Reference Number GA1-14012021-00012